October 18, 2023 — The following is an updated overview of the program Cardiovascular Research Foundation (CRF) annual scientific conference. It is Cardiovascular Catheter Therapeutics (TCT) Conference, TCT 2023, will take place October 23-26 at the Moscone Center in San Francisco, California. At a recent press briefing, highlights of the event, including the highly anticipated sessions, were previewed by CRF President and CEO, Juan Granada, MDwho was joined by the program directors Ajay J. Kirtane, MD, Columbia University (NY), and Roxana Mehran, MD, FACC, FACP, FAHA, FESC, FSCAI, Mount Sinai (NEW YORK).
The four-day event — with an expected attendance of 10,000 people this year, including 2,000 professors, according to Granada — is a global educational forum specializing in interventional cardiovascular medicine, offering a comprehensive, hands-on and interactive experience led by experts in coronary, structural diseases and endovascular interventions. TCT showcases cutting-edge research in interventional cardiovascular medicine that directly impacts patient care and how doctors treat heart disease.
Granada focused on the work of a large group of CRF faculty who helped develop the program, noting key strengths of TCT 2023 including:
- 27 late-breaking studies, including 12 late-breaking trials and 15 late-breaking scientific studies, selected from 175 submissions that represent the largest number of submissions in a decade
- Over 400 hours of educational programs
- 25 innovative sessions
- 28 featured clinical science sessions
- 44 live cases from 18 medical institutions around the world
- 774 moderated summaries
- 24 satellites
- 75+ exhibitors
- 4 rewards
- 19 learning tracks
- 15 types of sessions
“We’re really excited about the content and the programming,” Kirtane said, adding, “There will be a full range of what you would expect in endovascular, coronary and structural at TCT.”
“Over the years, you have seen how central TCT has become not only in terms of the training of interventional cardiologists, but, more importantly, the central place where the science of interventional cardiology, which is incredibly moving and constantly innovative in terms of disruptive therapies, appears. is the ground for this,” commented Mehran. Noting that this is her 28th year with TCT, which has served as her stage, she added: “This is the place where the next generation of leaders will emerge and we are committed to educating them, to highlight them, to elevate them, and to give them the platform they deserve to have.
For 2023, TCT program directors, in collaboration with nearly 50 world-renowned thought leaders serving on the program development committee, have designed a comprehensive program to drive engagement and interactive learning based on cases with a diverse range of faculty. They noted that attendees can expect to find in-depth, topic-focused, case-based hands-on sessions with featured clinical research and other notable sessions, hands-on training and extensive networking. Program highlights and session plans follow.
The keynote on Tuesday, October 26 at 9:30 a.m. will begin the second day of TCT 2023, followed by 6 clinical practice sessions, 6 moderated abstract presentations, 6 complex cases with the masters and a total of 24 spotlight sessions. Two of these highlight sessions will include American Heart Association (AHA) Hot Takes sessions, part of the AHA@TCT, which began last year.
The comprehensive program offers several session types, including: iCOACH clinical practice sessions; Clinical trials and late-breaking science; Complex affairs with the masters; Moderated summaries; Spotlight Sessions; and special events. Program planners have divided the wide range of sessions into a total of eight streams, including: coronary; Real cases; Mitral; Endovascular; Heart failure; Tricuspid; TAVR; and LAA/PFO, many of which will have Spotlight Theater to accommodate attendees.
Late-breaking clinical trials and scientific presentations will be presented Tuesday, Wednesday and Thursday from 11:00 a.m. to 12:30 p.m. and 2:00 p.m. to 3:30 p.m. DAIC will continue to provide detailed coverage of the sessions and results.
“Each of them has the opportunity to change their practice, and that’s really important,” Mehran noted of the results. “They are all relevant to clinical practice,” noted Kirtane, who added: “There are angles that will change things and the question is ‘how much will they change them?’ and it depends on the results, so we’re really excited to present the ones that we know about, and we’re really excited to find out the results of the ones that we don’t know about because I think they will inform the practice, especially in terms of interventional. side through the coronal and endovascular structural zones.
At the Structural Theater, on Tuesday October 24 and Thursday October 26, from 3:30 p.m. to 5:00 p.m., participants will have the opportunity to learn from more than 40 real cases presented remotely, which will be interpreted by renowned experts. from 18 of the world’s most distinguished medical institutions (listed on the TCT2023 event website), which planners enthusiastically report offer the opportunity to watch complex procedures performed live by the masters.
Throughout the Moscone Center, the FIU TCT program team establishes easily accessible areas for all educational and clinical programs. Six moderated abstract stations will showcase emerging clinical science and research throughout the event.
MedTech Innovation Forum to Feature FDA Commissioner
This year, TCT will once again host its TCT MedTech Innovation Forum, scheduled for Monday, October 23, from 8:00 a.m. to 5:45 p.m., followed by a networking reception from 5:45 p.m. to 6:45 p.m. The forum will have three components: global market dynamics; Hot topics in MedTech innovation; and FDA University for start-ups.
Granada offered this about the Forum: “We launched the TCT MedTech Innovation Forum last year with the aim of giving space to innovators and startups in the industry. There are many topics that need to be disclosed and where we need to hear the voice of industry, in collaboration with the FDA, incubators, innovators and investors. Last year we welcomed 1,500 people and this year we expect an attendance of around 2,000 people. The FDA University for Startups is a dedicated pathway where startups can meet the FDA and learn about the regulatory processes, needs, changes, requirements, etc. This session includes FDA Commissioner Robert M. Califf, MD, who will be part of it, as well as people from big tech. The closing session is very important because we actually have a large majority of CEOs from our industry present to have a roundtable discussion to discuss the issues, challenges and potential solutions that are occurring in the field.
Also on Monday, the TCT Shark Tank innovation competition will take place from 12:15 p.m. to 1:45 p.m.
The Nurses and Technologists Symposium will be presented Monday at TCT 2023, from 9:00 a.m. to 5:30 p.m. Described as the premier full-day forum for frontline nurses, advanced practice providers and technologists in cardiology or outside. catheterization laboratory, the Cardiovascular Research Foundation designates this live activity for a maximum of 7.75 AMA PRA Category 1 credits.
Kirtane, who completed his residency in San Francisco, has brought attention to TCT WorldLink, which will also take place Monday, to colleagues around the world, with three of them designated as future clinical science sessions. He also noted how many trials have the ability to change outcomes, and added that there is a comprehensive endovascular track. “Pulmonary embolism (PE) is a major area of focus this year as it is really growing in the interventional area, so look for it both on Innovation Day as well as in the stream sessions endovascular.
FDA Town Hall Highlighted in Tuesday Program Schedule
Tuesday’s FDA public meeting was another focus of the press conference, with Mehran enthusiastically noting the value of the discussions that have taken place in this area for nearly 20 years. “There are a lot of very, very important discussions going around, and I think there have been tremendous accomplishments in the first device feasibility program in the United States, as well as in some of the very important regulatory ecosystems with avenues of collaboration that have been put in place. set up for device approval…representing how everyone comes together to come up with the best innovation in devices and drugs, honestly and it will be presented at the FDA Town Hall.
Additionally, she added, “We decided with certainty that at City Hall we needed to address diversity and inclusion head-on in terms of how far we’ve come or how little we’ve progressed in terms of including populations. of patients who must be included in clinical trials, particularly for regulatory approval. There will now be a very, very high bar on the regulatory side for devices to be approved, so that the trials represent the patients who will receive them. We’re going to present that at the FDA town hall, and then a whole session on renal denervation, mitral and tricuspid valve devices, and heart failure. So these are exciting clinical areas that are really growing, and we need all the discussions around the table in an open town hall. I’m very excited about this year’s FDA public meeting…because I think if you really want to know what’s next in the future, you’ll want to come to these first two days.
TCT 2023 is CME accredited for participants who attend in person. Planners note that CME credits can be earned at the following accredited learning locations: Coronary Spotlight; Spotlight on structure; Spotlight on endovascular; and the Nurses and Technologists Symposium.
The Cardiovascular Research Foundation (CRF) is a nonprofit organization specializing in innovation, research and education in interventional cardiology, and is dedicated to helping physicians improve the survival and quality of life of people suffering from heart and vascular diseases. The Foundation reports that for more than 30 years, it has helped accelerate medical breakthroughs and train doctors in the latest treatments for heart disease. CRF Centers of Excellence include the CRF Skirball Center for Innovation, the CRF Clinical Trials Center, the CRF Center for Education, CRF Digital, TCTMD, and Structural Heart: The Journal of the Heart Team.
Follow DAIC TCT 2023 News Coverage before, during and after the Conference.